DLAT and primary biliary cholangitis: Given that PDC-E2 is widely expressed in liver cells and BECs are heterogeneous in phenotype1–3, it remains unclear why autoimmune responses preferably destroy small BECs in the liver of PBC patients regardless of the presence of AMAs, and which BECs are targeted in the early stages of PBC pathogenesis.